These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11788614)

  • 1. Tibolone for postmenopausal women: systematic review of randomized trials.
    Modelska K; Cummings S
    J Clin Endocrinol Metab; 2002 Jan; 87(1):16-23. PubMed ID: 11788614
    [No Abstract]   [Full Text] [Related]  

  • 2. Spanish Menopause Society position statement: use of tibolone in postmenopausal women.
    Mendoza N; Abad P; Baró F; Cancelo MJ; Llaneza P; Manubens M; Quereda F; Sánchez-Borrego R
    Menopause; 2013 Jul; 20(7):754-60. PubMed ID: 23793166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tibolone: the way to beat many a postmenopausal ailments.
    Lazovic G; Radivojevic U; Marinkovic J
    Expert Opin Pharmacother; 2008 Apr; 9(6):1039-47. PubMed ID: 18377345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone].
    Reginster JY
    J Gynecol Obstet Biol Reprod (Paris); 2002 Oct; 31(6):541-9. PubMed ID: 12407324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of bone loss with tibolone in postmenopausal women: results of two randomized, double-blind, placebo-controlled, dose-finding studies.
    Gallagher JC; Baylink DJ; Freeman R; McClung M
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4717-26. PubMed ID: 11600531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs. placebo in postmenopausal women.
    Hudita D; Posea C; Ceausu I; Rusu M
    Eur Rev Med Pharmacol Sci; 2003; 7(5):117-25. PubMed ID: 15214586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updated clinical recommendations for the use of tibolone in Asian women.
    Huang KE; Baber R;
    Climacteric; 2010 Aug; 13(4):317-27. PubMed ID: 20443720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial.
    Kroiss R; Fentiman IS; Helmond FA; Rymer J; Foidart JM; Bundred N; Mol-Arts M; Kubista E
    BJOG; 2005 Feb; 112(2):228-33. PubMed ID: 15663589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study.
    Swanson SG; Drosman S; Helmond FA; Stathopoulos VM
    Menopause; 2006; 13(6):917-25. PubMed ID: 17006377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tibolone decreases Lipoprotein(a) levels in postmenopausal women: A systematic review and meta-analysis of 12 studies with 1009 patients.
    Kotani K; Sahebkar A; Serban C; Andrica F; Toth PP; Jones SR; Kostner K; Blaha MJ; Martin S; Rysz J; Glasser S; Ray KK; Watts GF; Mikhailidis DP; Banach M;
    Atherosclerosis; 2015 Sep; 242(1):87-96. PubMed ID: 26186655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tibolone as an alternative to estrogen for the prevention of postmenopausal osteoporosis in selected postmenopausal women.
    Riggs BL
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2417-8. PubMed ID: 8675553
    [No Abstract]   [Full Text] [Related]  

  • 12. Tibolone: prevention of bone loss in late postmenopausal women.
    Bjarnason NH; Bjarnason K; Haarbo J; Rosenquist C; Christiansen C
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2419-22. PubMed ID: 8675554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials.
    Biglia N; Maffei S; Lello S; Nappi RE
    Gynecol Endocrinol; 2010 Nov; 26(11):804-14. PubMed ID: 20586550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tibolone and the promise of ideal hormone-replacement therapy.
    El-Hajj Fuleihan G
    N Engl J Med; 2008 Aug; 359(7):753-5. PubMed ID: 18703480
    [No Abstract]   [Full Text] [Related]  

  • 15. Tibolone relieves climacteric symptoms in highly symptomatic women with at least seven hot flushes and sweats per day.
    Landgren MB; Helmond FA; Engelen S
    Maturitas; 2005 Mar; 50(3):222-30. PubMed ID: 15734603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women.
    Laan E; van Lunsen RH; Everaerd W
    Climacteric; 2001 Mar; 4(1):28-41. PubMed ID: 11379375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmenopausal tibolone therapy: biologic principles and applied clinical practice.
    Notelovitz M
    MedGenMed; 2007 Jan; 9(1):2. PubMed ID: 17435612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drugs in development for the treatment of osteoporosis: Tibolone].
    Gorai I
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():552-71. PubMed ID: 11979954
    [No Abstract]   [Full Text] [Related]  

  • 19. Tibolone and the serum lipid/lipoprotein profile: does this have a role in cardiovascular protection in postmenopausal women?
    Ginsburg J; Prelevic GM
    Menopause; 1999; 6(2):87-9. PubMed ID: 10374212
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
    Ziaei S; Moghasemi M; Faghihzadeh S
    Climacteric; 2010 Apr; 13(2):147-56. PubMed ID: 19731119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.